Quantum BioPharma Ltd.

QNTM | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.73

+$0.12 (+3.32%)

Sep 22, 2026, 1:17 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.32%

(1D)

Rating

Updated: Aug 15, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $23.87M

1D Range

3.66 3.90

52W Range

2.07 19.42

Valuation (TTM)

PE -0.64

PB 2.91

EV/EBITDA -0.61

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target N/A

Cash Flow

FCF Yield -23.4%

SBC Adj. FCF Yield -35.1%

SBC Impact -49.8%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 25.0% | 37.8%

FCF 3Y | 5Y -1.6% | 35.8%

Returns

ROA -173.1%

ROE -413.1%

ROIC -27.1%

Financial Health

Net Cash

$8.77M

Current Ratio 1.20

Interest Coverage -5.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses ...

Sector Healthcare

Industry Biotechnology

Employees 17

IPO Date Jun 7, 2018

Website www.quantumbiopharma.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.